The sodium-glucose cotransporter 2 inhibitor luseogliflozin can suppress muscle atrophy in Db/Db mice by suppressing the expression of foxo1

We investigated the effect of the sodium glucose cotransporter-2 inhibitor (SGLT-2i) luseogliflozin on skeletal muscle. Eight-week-old mice were fed a standard diet or the standard diet with added luseogliflozin for 8 weeks. The mice were divided into the following four genotype/dietary groups: Db/m...

Descripción completa

Detalles Bibliográficos
Autores principales: Okamura, Takuro, Hashimoto, Yoshitaka, Osaka, Takafumi, Fukuda, Takuya, Hamaguchi, Masahide, Fukui, Michiaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: the Society for Free Radical Research Japan 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6667382/
https://www.ncbi.nlm.nih.gov/pubmed/31379410
http://dx.doi.org/10.3164/jcbn.18-114

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6667382/
https://www.ncbi.nlm.nih.gov/pubmed/31379410
http://dx.doi.org/10.3164/jcbn.18-114

Ejemplares similares